Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2°C

European Journal of Applied Physiology

Volumn 95, Issue 4, 2005, Pages 298-306

  Ahlers, Olaf ^a   Hildebrandt, Bert ^a   Dieing, Annette ^a   Deja, Maria ^a   Böhnke, Thomas ^a   Wust, Peter ^a   Riess, Hanno ^a   Gerlach, Herwig ^b   Kerner, Thoralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

Cytokines; Lymphocytes; Stress; Whole body hyperthermia

Indexed keywords

CARBOPLATIN; CYTOKINE; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GAMMA INTERFERON; IFOSFAMIDE; INTERLEUKIN 10; INTERLEUKIN 12; MITOMYCIN C;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GERM CELL TUMOR; HELPER CELL; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IMMUNE RESPONSE; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; OVARY CANCER; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPPRESSOR CELL; T LYMPHOCYTE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS; PILOT PROJECTS; STRESS;

EID: 30344481098     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-005-0009-4     Document Type: Article

References (55)

1. Ahlers O, Boehnke T, Kerner T, Deja M, Keh D, Loeffel J, Hildebrandt B, Riess H, Wust P, Pappert D, Gerlach H (1998) Leukocyte alterations during hyperthermia. Br J Anaesth 80:88
2. Alam R, Gorska M (2003) 3. Lymphocytes. J Allergy Clin Immunol 111:476-485 (DOI:10.1067/mai.2003.121)
3. Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18:309-345 (DOI:10.1146/ annurev.immunol.18.1.309)
4. Atanackovic D, Nierhaus A, Neumeier M, Hossfeld DK, Hegewisch-Becker S (2002) 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 51:603-613 (DOI:10.1007/ s00262-002-0327-x)
5. Bakhshandeh A, Bruns I, Traynor A, Robins HI, Eberhardt K, Demedts A, Kaukel E, Koschel G, Gatzemeier U, Kohlmann T, Dalhoff K, Ehlers EM, Gruber Y, Zumschlinge R, Hegewisch-Becker S, Peters SO, Wiedemann GJ (2003) Ifosfamide, carboplatin and etoposide combined with 41.8°C whole body hyperthermia for malignant pleural mesothelioma. Lung Cancer 39:339-345 (DOI:10.1016/S0169-5002(02)00536-6)
6. Ben Eliyahu S, Page GG, Yirmiya R, Shakhar G (1999) Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80:880-888 (DOI 10.1002/ (SICI)1097-0215(19990315)80:6<880::AID-IJC14>3.0.CO;2-Y)
7. Berry JM, Michalsen A, Nagle V, Bull JM (1997) The use of esmolol in whole-body hyperthermia: Cardiovascular effects. Int J Hyperthermia 13:261-268 9222810
8. Blazickova S, Rovensky J, Koska J, Vigas M (2000) Effect of hyperthermic water bath on parameters of cellular immunity. Int J Clin Pharmacol Res 20:41-46 11146901
9. Brand JM, Kirchner H, Poppe C, Schmucker P (1997) The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol 83:190-194 (DOI:10.1006/ clin.1997.4351)
10. Brenner IK, Zamecnik J, Shek PN, Shephard RJ (1997) The impact of heat exposure and repeated exercise on circulating stress hormones. Eur J Appl Physiol Occup Physiol 76:445-454 (DOI: 10.1007/s004210050274)
11. Breznitz S, Ben Zur H, Berzon Y, Weiss DW, Levitan G, Tarcic N, Lischinsky S, Greenberg A, Levi N, Zinder O (1998) Experimental induction and termination of acute psychological stress in human volunteers: Effects on immunological, neuroendocrine, cardiovascular, and psychological parameters. Brain Behav Immun 12:34-52 (DOI:10.1006/ brbi.1997.0511)
12. Carlson SL, Fox S, Abell KM (1997) Catecholamine modulation of lymphocyte homing to lymphoid tissues. Brain Behav Immun 11:307-320 (DOI:10.1006/brbi.1997.0501)
13. Chakravarti A (1995) The CD4/CD8 ratio: Message in a bottle? (comment). Nat Med 1:1240-1241 10.1038/nm1295-1240
14. Cross MC, Radomski MW, VanHelder WP, Rhind SG, Shephard RJ (1996) Endurance exercise with and without a thermal clamp: Effects on leukocytes and leukocyte subsets. J Appl Physiol 81:822-829 8872652
15. Dhabhar FS (2002) Stress-induced augmentation of immune function-the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun 16:785-798 (DOI:10.1016/S0889-1591(02)00036-3)
16. Dieing A, Ahlers O, Kerner T, Semmler S, Wust P, Felix R, Löffel J, Riess H, Hildebrandt B (2003) Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiol 207:265-273 (DOI:10.1078/0171-2985-00236)
17. Dong C, Flavell RA (2001) Th1 and Th2 cells. Curr Opin Hematol 8:47-51 10.1097/00062752-200101000-00009
18. Downing JF, Martinez Valdez H, Elizondo RS, Walker EB, Taylor MW (1988) Hyperthermia in humans enhances interferon-gamma synthesis and alters the peripheral lymphocyte population. J Interferon Res 8:143-150 3132509
19. Elenkov IJ, Chrousos GP (2002) Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966:290-303 12114286
20. Faithfull NS, Reinhold HS, van den Berg AP, van Rhoon GC, van der Zee J, Wike-Hooley JL (1984) Cardiovascular changes during whole body hyperthermia treatment of advanced malignancy. Eur J Appl Physiol Occup Physiol 53:274-281 10.1007/BF00776602
21. Gannon GA, Rhind SG, Shek PN, Shephard RJ (2001) Differential cell adhesion molecule expression and lymphocyte mobilisation during prolonged aerobic exercise. Eur J Appl Physiol 84:272-282 (DOI:10.1007/ s004210000374)
22. Gor DO, Rose NR, Greenspan NS (2003) TH1-TH2: A procrustean paradigm. Nat Immunol 4:503-505 (DOI:10.1038/ni0603-503)
23. Hammami MM, Bouchama A, Shail E, Aboul Enein HY, al Sedairy S (1998) Lymphocyte subsets and adhesion molecules expression in heatstroke and heat stress. J Appl Physiol 84:1615-1621 9572807
24. Haveman J, Geerdink AG, Rodermond HM (1996) Cytokine production after whole body and localized hyperthermia. Int J Hyperthermia 12:791-800 8950159
25. Hegewisch-Becker S, Gruber Y, Corovic A, Pichlmeier U, Atanackovic D, Nierhaus A, Hossfeld DK (2002) Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: A phase II study. Ann Oncol 13:1197-1204 (DOI:10.1093/ annonc/mdf216)
26. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43:33-56 (DOI:10.1016/S1040-8428(01)00179-2)
27. Hildebrandt B, Draeger J, Kerner T, Deja M, Loeffel J, Stroszczynski C, Ahlers O, Felix R, Riess H, Wust P (2004) Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: A phase I/II study. Int J Hyperthermia 20:317-333 (DOI:10.1080/ 02656730310001637316)
28. Hildebrandt B, Hegewisch-Becker S, Kerner T, Nierhaus A, Bakhshandeh-Bath A, Janni W, Sommer H, Riess H, Wust P (2005) Current status of radiant whole body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. The German "Interdisciplinary Working Group on Hyperthermia". Int J Hyperthermia 21:169-183 (DOI: 10.1080/02656730400003401)
29. Iwakabe K, Shimada M, Ohta A, Yahata T, Ohmi Y, Habu S, Nishimura T (1998) The restraint stress drives a shift in Th1/Th2 balance toward Th2-dominant immunity in mice. Immunol Lett 62:39-43 (DOI:10.1016/ S0165-2478(98)00021-2)
30. Jessop DS (1999) Stimulatory and inhibitory regulators of the hypothalamo-pituitary-adrenocortical axis. Baillieres Best Pract Res Clin Endocrinol Metab 13:491-501 10.1053/beem.1999.0039
31. von Kanel R, Mills PJ, Dimsdale JE (2001) Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sci 69:255-262 (DOI:10.1016/S0024-3205(01)01127-4)
32. Kappel M, Stadeager C, Tvede N, Galbo H, Pedersen BK (1991) Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol 84:175-180 2015709
33. Katschinski DM, Wiedemann GJ, Longo W, d'Oleire FR, Spriggs D, Robins HI (1999) Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy. Cytokine Growth Factor Rev 10:93-97 (DOI:10.1016/ S1359-6101(99)00006-4)
34. Kearns RJ, Ringler S, Krakowka S, Tallman R, Sites J, Oglesbee MJ (1999) The effects of extracorporal whole body hyperthermia on the functional and phenotypic features of canine peripheral blood mononuclear cells (PBMC). Clin Exp Immunol 116:188-192 (DOI:10.1046/ j.1365-2249.1999.00849.x)
35. Kerner T, Deja M, Ahlers O, Loffel J, Hildebrandt B, Wust P, Gerlach H, Riess H (1999) Whole body hyperthermia: A secure procedure for patients with various malignancies? [see comments]. Intensive Care Med 25:959-965 (DOI:10.1007/s001340050989)
36. Kerner T, Hildebrandt B, Ahlers O, Deja M, Riess H, Draeger J, Wust P, Gerlach H (2003) Anaesthesiological experiences with whole body hyperthermia. Int J Hyperthermia 19:1-12 (DOI:10.1080/02656730210143596)
37. Kohm AP, Sanders VM (2001) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487-525 11734616
38. Kraybill WG, Olenki T, Evans SS, Ostberg JR, O'Leary KA, Gibbs JF, Repasky EA (2002) A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: Correlation with mouse models. Int J Hyperthermia 18:253-266 (DOI:10.1080/02656730110116704)
39. Madden KS, Sanders VM, Felten DL (1995) Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35:417-448 10.1146/annurev.pa.35.040195.002221
40. Mak TW, Ferrick DA (1998) The gamma-delta T-cell bridge: Linking innate and acquired immunity. Nat Med 4:764-765 (DOI: 10.1038/nm0798-764)
41. Marshall GD, Agarwal SA, Lloyd C, Cohen L, Henninger EM, Morris GJ (1998) Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav Immun 98:297-307 (DOI:10.1006/ brbi.1998.0537)
42. Motulsky HJ, Insel PA (1982) Adrenergic receptors in man: Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 307:18-29 6123082
43. Pedersen BK, Hoffman Goetz L (2000) Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80:1055-1081 10893431
44. Repasky E, Issels R (2002) Physiological consequences of hyperthermia: heat, heat shock proteins and the immune response. Int J Hyperthermia 18:486-489 (DOI:10.1080/0265673021000036531)
45. Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438 2265240
46. Robins HI, Kalin NH, Shelton SE, Martin PA, Shecterle LM, Barksdale CM, Neville AJ, Marshall J (1987) Rise in plasma beta-endorphin, ACTH, and cortisol in cancer patients undergoing whole body hyperthermia. Horm Metab Res 19:441-443 2826324
47. Robins HI, Kutz M, Wiedemann GJ, Katschinski DM, Paul D, Grosen E, Tiggelaar CL, Spriggs D, Gillis W, D'Oleire F (1995) Cytokine induction by 41.8°C whole body hyperthermia. Cancer Lett 97:195-201 (DOI:10.1016/0304-3835(95)03976-4)
48. Shen RN, Lu L, Young P, Shidnia H, Hornback NB, Broxmeyer HE (1994) Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells. Int J Radiat Oncol Biol Phys 29:821-826 8040029
49. Smith LL, Anwar A, Fragen M, Rananto C, Johnson R, Holbert D (2000) Cytokines and cell adhesion molecules associated with high-intensity eccentric exercise. Eur J Appl Physiol 82:61-67 (DOI:10.1007/ s004210050652)
50. Steensberg A, Morrow J, Toft AD, Bruunsgaard H, Pedersen BK (2002) Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes. Eur J Appl Physiol 87:38-42 (DOI:10.1007/s00421-002-0584-6)
51. Westermann AM, Wiedemann GJ, Jager E, Jager D, Katschinski DM, Knuth A, Vorde Sive Vording PZ, Van Dijk JD, Finet J, Neumann A, Longo W, Bakhshandeh A, Tiggelaar CL, Gillis W, Bailey H, Peters SO, Robins HI (2003) A systemic hyperthermia oncologic working group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8°C whole-body hyperthermia for metastatic soft tissue sarcoma. Oncology 64:312-321 (DOI:10.1159/000070287)
52. Wust P, Riess H, Hildebrandt B, Loeffel J, Deja M, Ahlers O, Kerner T, von Ardenne A, Felix R (2000) Feasibility and analysis of thermal parameters for the whole-body-hyperthermia system IRATHERM-2000. Int J Hyperthermia 16(4):325-339 (DOI:10.1080/02656730050074096)
53. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3:487-497 (DOI:10.1016/S1470-2045(02)00818-5)
54. Yang H, Lauzon W, Lemaire I (1992) Effects of hyperthermia on natural killer cells: Inhibition of lytic function and microtubule organization. Int J Hyperthermia 8:87-97 1545166
55. van der Zee J (2002) Heating the patient: A promising approach?. Ann Oncol 13:1173-1184 (DOI:10.1093/annonc/mdf280)